Vistagen Therapeutics, Inc. (VTGN)

CIK 1411685 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Vistagen Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 30, 20268-K0001628280-26-068627
Oct 9, 20268-K0001628280-26-065559
Sep 25, 20268-K0001628280-26-063510
Sep 24, 20268-K0001628280-26-063316
Sep 22, 20268-K0001628280-26-063046
Sep 11, 20268-K0001628280-26-061445
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352371
Aug 14, 202610-Q0001628280-26-057116
Aug 14, 2026SCHEDULE 13G/A0001831942-26-000032
Aug 14, 20268-K0001628280-26-056953
Aug 14, 2026SCHEDULE 13G/A0000947871-26-000804
Aug 6, 20268-K0001628280-26-054341
Aug 5, 20268-K0001628280-26-053304
Jul 31, 2026DEF 14A0001628280-26-051404
Jul 31, 202630001911501-26-000004
Jul 31, 202640001911501-26-000006
Jul 31, 2026DEFA14A0001628280-26-051406
Jul 31, 20268-K0001628280-26-051251
Jul 2, 202640001924908-26-000007
Jul 2, 202640001794362-26-000004
Jul 2, 202640001412071-26-000006
Jun 30, 20268-K0001628280-26-046143
Jun 17, 20268-K0001628280-26-043989
Jun 15, 202610-K0001628280-26-043271
Jun 15, 20268-K0001628280-26-043232